Kyowa Kirin Co., Ltd.: Hyperparathyroidism trials

The registry lists 11 Hyperparathyroidism studies with Kyowa Kirin Co., Ltd. as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 2Phase 2 3Phase 3 6Phase 4 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary HyperparathyroidismCompletedNCT03280264Phase 3Results posted
• Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in AsiaCompletedNCT03822507Phase 3
• Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPTCompletedNCT03123406Phase 4
• Phase 3 Study of KHK7580CompletedNCT02549417Phase 3
• Phase 3 Study of KHK7580CompletedNCT02549404Phase 3
• Phase 3 Study of KHK7580CompletedNCT02549391Phase 2/3
• Phase 2 Study of KHK7580CompletedNCT02216656Phase 2
• Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal DialysisCompletedNCT02143271Phase 1
• Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving HemodialysisCompletedNCT01935856Phase 1/2
• An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary HyperparathyroidismCompletedNCT01460030Phase 3
• Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney DiseaseCompletedNCT00995163